JFK Communications was the global PR agency for S-1 (Teysuno) for the first-line treatment of advanced gastric cancer. JFK Communications provided extensive global corporate and product public relations, including:

US and EU regulatory milestone support
Data communications
Media relations
Medical meeting support
KOL development and media training
Oncology Drugs Advisory Committee meeting support
Issues management
Advocacy relations 

Reach Out

Ready to tell your story ?